Rolipram, a Phosphodiesterase Inhibitor, in the Treatment of Two Male Patients with Congenital Nephrogenic Diabetes insipidus [PDF]
Daniel G. Bichet+3 more
openalex +1 more source
A Stereoselective Synthesis of (R)-(-)-rolipram from L-Glutamic Acid [PDF]
Andrés Emanuel Díaz+4 more
openalex +1 more source
PDE4 inhibitors: potential protective effects in inflammation and vascular diseases. [PDF]
Fan T+6 more
europepmc +1 more source
Disruption of GPSM1/CSF1 signaling reprograms tumor-associated macrophages to overcome anti-PD-1 resistance in colorectal cancer. [PDF]
Chen Y+7 more
europepmc +1 more source
Targeting Aquaporin-5 by Phosphodiesterase 4 Inhibition Offers New Therapeutic Opportunities for Ovarian Ischemia Reperfusion Injury in Rats. [PDF]
Bozkurt A+6 more
europepmc +1 more source
Drugs to affect the smooth musculature of the human ureter - an update with integrated information from basic science to the use in medical expulsion therapy (MET). [PDF]
Hedlund P+4 more
europepmc +1 more source
PDE4B promotes JNK/NLRP3 activation in the nucleus pulposus and mediates intervertebral disc degeneration. [PDF]
Xu W+10 more
europepmc +1 more source
The Hidden Potential of PDE4 Inhibitor Rolipram: A Multifaceted Examination of its Inhibition of MMP2/9 Reveals Theraputic Implications [PDF]
Arka Bagchi+3 more
openalex +1 more source
The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction. [PDF]
Hong JM+5 more
europepmc +1 more source
PDE4D: A Multipurpose Pharmacological Target. [PDF]
Lusardi M+3 more
europepmc +1 more source